Abstract:
The invention relates to a preparative method of obtaining a highly purified preparation of an aspartic protease, chymosin C. The invention further relates to the use of chymosin C in milk coagulating compositions in cheese manufacturing based on cow's milk and milk from any animal species, which are used in cheese.
Abstract:
A method of providing polypeptide preparations having a reduced content of undesired enzymatic side activities, the method comprising subjecting a medium containing a desired polypeptide such as an enzyme, a pharmaceutically active or immunologically active polypeptide to a pH of less than 2 for a period of time that is required to inactivate the side activities whilst retaining the activity of the desired polypeptide. The method is useful for providing milk clotting enzyme products including rennets or coagulants based on chymosin or pepsin or microbial aspartic proteases e.g. derived from bacterial species and species of filamentous fungi.
Abstract:
Rhizomucor miehei derived aspartic proteases having enhanced milk clotting activity are obtained by deglycosylating the proteases or by producing them in microbial host species which do not glycosylate the proteases or which glycosylate them to lesser extend than Rhizomucor miehei strains naturally producing aspartic proteases in a glycosylated form. Such improved proteases are useful in cheese manufacturing.
Abstract:
A process of separating milk clotting enzymes in extracts of animal stomach tissue which comprises contacting a partially purified extract with an ion exchange resin under conditions where chymosin is bound to the resin and recovering the chymosin, the process optionally comprising the further step of recovering pepsin, from a pepsin-rich extract fraction using an ion exchange resin, and a liquid or powdered rennet composition containing at least 90 % of its milk clotting activity as chymosin activity, the composition comprising a chymosin stabilizing agent which is typically selected from a protein, a peptide, an amino acid or ascorbic acid.
Abstract:
A process of separating milk clotting enzymes in extracts of animal stomach tissue which comprises contacting a partially purified extract with an ion exchange resin under conditions where chymosin is bound to the resin and recovering the chymosin, the process optionally comprising the further step of recovering pepsin, from a pepsin-rich extract fraction using an ion exchange resin, and a liquid or powdered rennet composition containing at least 90 % of its milk clotting activity as chymosin activity, the composition comprising a chymosin stabilizing agent which is typically selected from a protein, a peptide, an amino acid or ascorbic acid.
Abstract:
The present invention relates to methods for coagulating bovine milkand making cheese using a coagulant substantially identical to a chymosin originating from an animal of the Tylopoda suborder.
Abstract:
The invention relates to a preparative method of obtaining a highly purified preparation of an aspartic protease, chymosin C. The invention further relates to the use of chymosin C in milk coagulating compositions in cheese manufacturing based on cow's milk and milk from any animal species, which are used in cheese.
Abstract:
A method of providing polypeptide preparations having a reduced content of undesired enzymatic side activities, the method comprising subjecting a medium containing a desired polypeptide such as an enzyme, a pharmaceutically active or immunologically active polypeptide to a pH of less than 2 for a period of time that is required to inactivate the side activities whilst retaining the activity of the desired polypeptide. The method is useful for providing milk clotting enzyme products including rennets or coagulants based on chymosin or pepsin or microbial aspartic proteases e.g. derived from bacterial species and species of filamentous fungi.
Abstract:
A method of providing polypeptide preparations having a reduced content of undesired enzymatic side activities, the method comprising subjecting a medium containing a desired polypeptide such as an enzyme, a pharmaceutically active or immunologically active polypeptide to a pH of less than 2 for a period of time that is required to inactivate the side activities whilst retaining the activity of the desired polypeptide. The method is useful for providing milk clotting enzyme products including rennets or coagulants based on chymosin or pepsin or microbial aspartic proteases e.g. derived from bacterial species and species of filamentous fungi.
Abstract:
In a process for producing cheese from milk, an inactive milk-clotting enzyme and optionally chymosin or another suitable proteolytic enzyme is added to the milk, optionally simultaneously with or after adding a starter culture, to form a curd, at least part of the inactive enzyme is activated, and the resulting curd is converted to the ripened cheese. The milk employed is preferably concentrated milk, and the inactive milk-clotting enzyme is preferably prochymosin.